Holen Sie sich die Stockscreener-App
22.29
4.66%
-1.09
Handel nachbörslich:
22.18
-0.11
-0.49%
Schlusskurs vom Vortag:
$23.38
Offen:
$23.68
24-Stunden-Volumen:
894.49K
Relative Volume:
1.14
Marktkapitalisierung:
$1.20B
Einnahmen:
$312.78M
Nettoeinkommen (Verlust:
$-143.56M
KGV:
-8.2862
EPS:
-2.69
Netto-Cashflow:
$1.22M
1W Leistung:
-9.02%
1M Leistung:
-1.81%
6M Leistung:
-33.18%
1J Leistung:
+170.51%
1-Tages-Spanne:
$22.24
$24.02
1-Wochen-Bereich:
$22.24
$25.55
52-Wochen-Spanne:
$7.42
$34.84
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Vergleichen Sie CDNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
22.29 | 1.20B | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
532.55 | 203.70B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.23 | 151.18B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
135.37 | 38.62B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
452.77 | 37.07B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
191.04 | 33.64B | 15.41B | 1.37B | 2.11B | 7.50 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
| 2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2021-07-20 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-26 | Eingeleitet | BTIG Research | Buy |
| 2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
| 2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
| 2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Eingeleitet | Jefferies | Buy |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
| 2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-14 | Bestätigt | Mizuho | Buy |
| 2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Eingeleitet | Craig Hallum | Buy |
| 2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders - Business Wire
CareDx’s AlloSeq cfDNA Matches AlloSure Test Performance By Investing.com - Investing.com Nigeria
CareDx (CDNA) to Release Earnings on Wednesday - MarketBeat
CareDx, Inc. Announces Study Showing Alloseq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients - Marketscreener.com
CareDx's AlloSeq cfDNA Matches AlloSure Test Performance By Investing.com - Investing.com South Africa
CareDx's AlloSeq cfDNA Matches AlloSure Test Performance - Investing.com
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients - News Hub
Allspring Global Investments Holdings LLC Raises Stock Holdings in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
StockNews.com Downgrades CareDx (NASDAQ:CDNA) to Hold - MarketBeat
CareDX, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information - ACCESS Newswire
CareDx (NASDAQ:CDNA) Trading Down 5.5%Time to Sell? - MarketBeat
CareDx, Inc (NASDAQ:CDNA) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
CareDx (NASDAQ:CDNA) Sees Large Volume IncreaseStill a Buy? - MarketBeat
A company insider recently sold 3,512 shares of Caredx Inc [CDNA]. Should You Sale? - Knox Daily
Exploring Three High Growth Tech Stocks In The United States - Yahoo Finance
CareDx’s AlloHeme Shows Accuracy in Detecting Relapse Following AlloHSCT in AML and MDS - CGTLive™
Caredx Inc (CDNA) expanding its growth trajectory ahead - SETE News
Revolutionary Cancer Detection: CareDx Study Reveals 36-Day Early Warning System for Leukemia Relapse - StockTitan
CAREDX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against CareDx, Inc.CDNA - ACCESS Newswire
CareDx (CDNA) Soars 11.2%: Is Further Upside Left in the Stock? - MSN
Market Momentum: Caredx Inc (CDNA) Registers a -8.43 Decrease, Closing at 22.81 - The Dwinnex
Investing in CareDx (NASDAQ:CDNA) a year ago would have delivered you a 187% gain - Yahoo Finance
CareDx (NASDAQ:CDNA) Trading Down 5.5% – Here’s Why - Defense World
Caredx Inc [CDNA] Stock sold by Insider Novack Jeffrey Adam for $81829.0 - Knox Daily
CareDx to Report Fourth Quarter and Full Year 2024 Financial Results - The Bakersfield Californian
Calamos Advisors LLC Cuts Stock Holdings in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Adversity is less terrifying than hope: Caredx Inc (CDNA) - SETE News
Market Insights: Caredx Inc (CDNA)’s Notable Gain of 2.12, Closing at 23.59 - The Dwinnex
Does CareDx (CDNA) Have the Potential to Rally 42.25% as Wall Street Analysts Expect? - Yahoo Finance
Did Caredx Inc (CDNA) perform well in the last session? - US Post News
Wells Fargo upgrades Caredx Inc (CDNA) stock to an Equal weight - Knox Daily
Brokerages Set CareDx, Inc (NASDAQ:CDNA) Price Target at $28.33 - MarketBeat
SG Americas Securities LLC Purchases 5,706 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
CareDx, Inc (NASDAQ:CDNA): Are Analysts Optimistic? - Simply Wall St
CareDx, Inc (NASDAQ:CDNA) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Vanguard Group Inc. Increases Stake in CareDx Inc. - GuruFocus.com
Is CareDx (CDNA) Outperforming Other Medical Stocks This Year? - Yahoo Finance
CareDx (CDNA) Traded Down Due to Disappointing Quarterly Results - MSN
CareDx (NASDAQ:CDNA) Trading Down 5.4%Should You Sell? - MarketBeat
Here’s Why CareDx (CDNA) Traded Lower in Q4 - Insider Monkey
Leidos teams with CareDx to transform the Organ Procurement and Transplantation Network - Leidos
Best Momentum Stocks to Buy for January 21st - Yahoo Finance
Wells Fargo upgrades CareDx after a 30% pullback in stock - MSN
CareDx, Inc (NASDAQ:CDNA) Sees Significant Growth in Short Interest - MarketBeat
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.06%
3.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):